Using the Johns Hopkins' Aggregated Diagnosis Groups (ADGs) to predict 1-year mortality in population-based cohorts of patients with diabetes in Ontario, Canada

Diabetic Medicine

Volumn 29, Issue 9, 2012, Pages 1134-1141

  Austin, P C ^a,b,c   Shah, B R ^a,b,d,e   Newman, A ^a   Anderson, G M ^a,b  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b Department of Health Management Policy and Evaluation ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Adjusted Clinical Groups; Administrative data; Aggregated Diagnosis Groups; Charlson comorbidity index; Comorbidity; Health services research

Indexed keywords

ADULT; AGED; ALLERGY; ARTICLE; ASTHMA; CANADA; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DIABETIC PATIENT; DISEASE CLASSIFICATION; FEMALE; HUMAN; INFECTION; JOHN HOPKIN AGGREGATED DIAGNOSIS GROUP; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS; DIAGNOSIS-RELATED GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ONTARIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK ADJUSTMENT; SURVIVAL RATE; TIME FACTORS;

EID: 84865143489     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03568.x     Document Type: Article

References (25)

1. Iezzoni LI (editor). Risk Adjustment for Measuring Health Outcomes, 2nd edn. Chicago, IL: Health Administration Press, 1997.
2. Brookhart MA, Sturmer T, Glynn RJ, Rassen J, Schneeweiss S. Confounding control in healthcare database research: challenges and potential approaches. Med Care 2010; 48: S114-S120.
3. The Johns Hopkins University Bloomberg School of Public Health, Health Services Research & Development Center. The Johns Hopkins ACG® Case-Mix System Version 6.0 Release Notes (Jonathan P. Weiner ed. in Chief). Baltimore, MD: Johns Hopkins University, 2003.
4. Johns Hopkins University. Johns Hopkins ACG Case-Mix Adjustment System. Available at http://www.acg.jhsph.edu Last accessed 29 July 2010.
5. Weiner J, Starfield B, Steinwachs D, Abramson J. Development and application of a population-oriented measure of ambulatory care case-mix. Med Care 1991; 29: 452-472.
6. Starfield B, Weiner J, Murla P. Ambulatory care groups: A categorization of diagnoses for research and management. Health Serv Res 1991; 26: 53-74.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
8. Austin PC, van Walraven C, Wodchis WP, Newman A, Anderson GM. Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care 2011; 49: 932-939.
9. Austin PC, van Walraven C. The Mortality Risk Score and the ADG Score: two points-based scoring systems for the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada. Med Care 2011; 49: 940-947.
10. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512-516.
11. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
12. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004; 57: 1288-1294.
13. Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer-Verlag, 2001.
14. Steyerberg EW. Clinical Prediction Models. New York, NY: Springer-Verlag, 2009.
15. Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. N Engl J Med 1993; 328: 1092-1096.
16. Hogan CH, Lunney J, Gabel J, Lynn J. Medicare beneficiaries' costs of care in the last year of life. Health Aff 2001; 20: 188-195.
17. Lipscombe LL, Gomes T, Lévesque LE, Hux JE, Juurlink DN, Alter DA. Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA 2007; 298: 2634-2643.
18. Kerr EA, Gerzoff RB, Krein SL, Selby JV, Piette JD, Curb JD et al. Diabetes care quality in the Veterans Affairs health care system and commercial managed care: the TRIAD study. Ann Intern Med 2004; 141: 272-81.
19. Bowker SL, Majumdar SR, Veugelers P, Johnson JA. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006; 29: 254-258.
20. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians? Diabetes Care 2005; 28: 600-606.
21. Perkins AJ, Kroenke K, Unützer J, Katon W, Williams JH Jr, Hope C et al. Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol 2004; 57: 1040-1048.
22. Pietz K, Petersen LA. Comparing self-reported health status and diagnosis-based risk adjustment to predict 1- and 2-5 year mortality. Health Serv Res 2007; 42: 629-643.
23. Berlowitz DR, Hoenig G, Cowper DC, Duncan PW, Vogel WB. Impact of comorbidities on stroke rehabilitation outcomes: does the method matter? Arch Phys Med Rehabil 2008; 89: 1903-1906.
24. Petersen LA, Pietz K, Woodard LD, Byrne M. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. Med Care 2005; 43: 61-67.
25. Fan VS, Maciejewski ML, Liu CF, McDonell MB, Fihn SD. Comparison of risk adjustment measures based on self-report, administrative data, and pharmacy records to predict clinical outcomes. Health Serv Outcomes Res Methodol 2006; 6: 21-36.